Loading…
Details
- Subclass of
- inflammatory bowel diseases
- drug or therapy used for treatment
- ustekinumab, cholecalciferol, steroid, aminosalicylate, antibiotic, TNF inhibitor, immunosuppressive drug, targeted therapy, methotrexate
- genetic association
- IL23R, RUNX3, JAK2, STAT3, PSORS1C3, SP140, CPEB4, LACC1, IFNGR2, NOD2, ZMIZ1, SOCS1
- health specialty
- gastroenterology
- ICD-9-CM
- 555.1
- medical examination
- biopsy, medical imaging
- named after
- Burrill Bernard Crohn
- risk factor
- first-degree relative, smoking, antibiotic, urbanity, appendicitis, tonsillectomy
- social media followers
- 50593
- symptoms and signs
- diarrhea, weight loss, abdominal pain, fatigue
- topic's main category
- Category:Crohn's disease
Connected on Wikidata
Subject of
- CC Japan
- Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis
- Walnut Oral Immunotherapy for Tree Nut Allergy (2014-02-28)
- Evaluation of the Intubating Laryngeal Airway in Children (2009-12-31)
- Evaluation of the Intubating Laryngeal Airway in Children (2009-03-31)
- Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients (2008-08-31)
- Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
- Study in Patients With Asthma (2002-07-31)
- Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease (2005-08-31)
- A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Nothing in the MetaHistoryBook collection references this item yet.